scholarly journals Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases

2017 ◽  
Vol 45 (10) ◽  
pp. 1370-1371 ◽  
Author(s):  
R. Felwick ◽  
J. R. F. Cummings
Sign in / Sign up

Export Citation Format

Share Document